251 related articles for article (PubMed ID: 31833626)
1. Covalent Small Molecules as Enabling Platforms for Drug Discovery.
Dalton SE; Campos S
Chembiochem; 2020 Apr; 21(8):1080-1100. PubMed ID: 31833626
[TBL] [Abstract][Full Text] [Related]
2. Covalent fragment libraries in drug discovery.
Keeley A; Petri L; Ábrányi-Balogh P; Keserű GM
Drug Discov Today; 2020 Jun; 25(6):983-996. PubMed ID: 32298798
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery considerations in the development of covalent inhibitors.
Mah R; Thomas JR; Shafer CM
Bioorg Med Chem Lett; 2014 Jan; 24(1):33-9. PubMed ID: 24314671
[TBL] [Abstract][Full Text] [Related]
4. ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries.
Jiang L; Liu S; Jia X; Gong Q; Wen X; Lu W; Yang J; Wu X; Wang X; Suo Y; Li Y; Uesugi M; Qu ZB; Tan M; Lu X; Zhou L
J Am Chem Soc; 2023 Nov; 145(46):25283-25292. PubMed ID: 37857329
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors.
Lu X; Smaill JB; Patterson AV; Ding K
J Med Chem; 2022 Jan; 65(1):58-83. PubMed ID: 34962782
[TBL] [Abstract][Full Text] [Related]
6. Reactive-cysteine profiling for drug discovery.
Maurais AJ; Weerapana E
Curr Opin Chem Biol; 2019 Jun; 50():29-36. PubMed ID: 30897495
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments.
Petri L; Ábrányi-Balogh P; Tímea I; Pálfy G; Perczel A; Knez D; Hrast M; Gobec M; Sosič I; Nyíri K; Vértessy BG; Jänsch N; Desczyk C; Meyer-Almes FJ; Ogris I; Golič Grdadolnik S; Iacovino LG; Binda C; Gobec S; Keserű GM
Chembiochem; 2021 Feb; 22(4):743-753. PubMed ID: 33030752
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges.
Zeng S; Huang W; Zheng X; Liyan Cheng ; Zhang Z; Wang J; Shen Z
Eur J Med Chem; 2021 Jan; 210():112981. PubMed ID: 33160761
[TBL] [Abstract][Full Text] [Related]
9. Covalent hits and where to find them.
Lucas SCC; Blackwell JH; Hewitt SH; Semple H; Whitehurst BC; Xu H
SLAS Discov; 2024 Apr; 29(3):100142. PubMed ID: 38278484
[TBL] [Abstract][Full Text] [Related]
10. Activity-Based Protein Profiling (ABPP) of Oxidoreductases.
Fuerst R; Breinbauer R
Chembiochem; 2021 Feb; 22(4):630-638. PubMed ID: 32881211
[TBL] [Abstract][Full Text] [Related]
11. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
Ferreira LG; Andricopulo AD
Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
[TBL] [Abstract][Full Text] [Related]
12. Advances at the intersection of chemical biology and medicinal chemistry.
Tavassoli A
Future Med Chem; 2015; 7(16):2089-90. PubMed ID: 26571116
[No Abstract] [Full Text] [Related]
13. Elucidating the Catalytic Power of Glutamate Racemase by Investigating a Series of Covalent Inhibitors.
Vance NR; Witkin KR; Rooney PW; Li Y; Pope M; Spies MA
ChemMedChem; 2018 Dec; 13(23):2514-2521. PubMed ID: 30264520
[TBL] [Abstract][Full Text] [Related]
14. Covalent fragment libraries in drug discovery-Design, synthesis, and screening methods.
Hocking B; Armstrong A; Mann DJ
Prog Med Chem; 2023; 62():105-146. PubMed ID: 37981350
[TBL] [Abstract][Full Text] [Related]
15. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated mechanism-based inhibitors: common themes and recent developments.
Tysoe C; Withers SG
Curr Top Med Chem; 2014; 14(7):865-74. PubMed ID: 24484426
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery for a new generation of covalent drugs.
Kalgutkar AS; Dalvie DK
Expert Opin Drug Discov; 2012 Jul; 7(7):561-81. PubMed ID: 22607458
[TBL] [Abstract][Full Text] [Related]
18. Covalent inhibition of the lymphoid tyrosine phosphatase.
Ahmed VF; Bottini N; Barrios AM
ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in identifying protein targets in drug discovery.
Ha J; Park H; Park J; Park SB
Cell Chem Biol; 2021 Mar; 28(3):394-423. PubMed ID: 33357463
[TBL] [Abstract][Full Text] [Related]
20. Seeing small molecules in action with bioorthogonal chemistry.
Raghavan AS; Hang HC
Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
